Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the delivery of SR-T100 from the topical gel (containing
2.3% solamargine in Solanum undatum plant extract) by determining the plasma levels of
solamargine in subjects with AK while administration of a 25 cm2 contiguous or non-contiguous
dermal treatment area.